MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Healthcare utilization in individuals with late onset versus adult-onset Huntington’s disease

J. Ta, TM. To, A. Patel, I. Abbass, S. Arndorfer, R. Ghandy (South San Francisco, USA)

Meeting: MDS Virtual Congress 2021

Abstract Number: 251

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Treatment

Category: Huntington's Disease

Objective: To assess healthcare utilization (HCU) among patients (pts) with late-onset Huntington’s disease (LoHD) versus adult-onset HD (AoHD) and non-HD controls.

Background: HD typically manifests between ages 30 and 50 years (y), but LoHD can occur in pts aged ≥60y. Little is known about the relative burden of LoHD compared with AoHD.

Method: This retrospective cohort study used the IBM® MarketScan Commercial and Medicare Supplemental databases from 2008–2018. We identified pts with newly diagnosed HD, defined as having ≥1 HD diagnosis (ICD-9-CM: 333.4; ICD-10-CM: G10) from 2009–2017, aged ≥21y at first HD diagnosis (index date) with no HD claims for 12 months pre-index. Pts with HD aged 21–59y were identified as having AoHD; those ≥60y were identified as having LoHD. Pts without HD (non-HD controls) were exact matched 2:1 to pts with HD on age, sex and insurance type, and propensity score matched on Charlson Comorbidity Index (CCI), health plan, region and baseline HCU. All pts had continuous enrollment for ≥12 months pre- and post-index. Patient characteristics at baseline and HD stage (determined by diagnoses and services in claims 6 months post-index)[1] were described. Multivariable logistic regression models adjusted for age, sex, HD diagnosis, insurance type, propensity score, and interaction between HD diagnosis and age were used to estimate predicted probabilities for all-cause HCU among pts with LoHD, pts with AoHD and non-HD controls during the 12-month post-index period.

Results: In total, 763 pts with LoHD (median [interquartile range; IQR] age: 70y [63–77]; 56.5% female; mean [SD] CCI=1.49 [2.13]) were matched to 1,526 controls; 1,073 pts with AoHD (median [IQR] age: 50y [42–55]; 55.1% female; mean [SD] CCI=0.56 [1.39]) were matched to 2,146 controls. Nearly 67.4% of pts with LoHD and 49.8% of pts with AoHD had middle- or late-stage disease. After adjusting for baseline characteristics, pts with LoHD or AoHD had a significantly higher probability of HCU across all medical service categories compared with non-HD controls during the 12-month post-index period [table1]. Compared with pts with AoHD, pts with LoHD had similar probability of hospitalizations, long-term care/nursing home, skilled nursing facility and ER visits, but lower probability of physician office visits [table1].

Conclusion: Pts with LoHD and AoHD have similar HCU burden, which is significantly higher compared with those without HD.

MDS Lohd vs AoHD Table 1

References: 1. Divino V, et al. J Med Econ. 2013; 16:1043–50.

To cite this abstract in AMA style:

J. Ta, TM. To, A. Patel, I. Abbass, S. Arndorfer, R. Ghandy. Healthcare utilization in individuals with late onset versus adult-onset Huntington’s disease [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/healthcare-utilization-in-individuals-with-late-onset-versus-adult-onset-huntingtons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/healthcare-utilization-in-individuals-with-late-onset-versus-adult-onset-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley